TrialJournal of virology2011

H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans.

Surender Khurana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.